Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kaletra Tablets vs Soft-Gel Capsules in African Americans
NCT00268827Phase 4Completed
- Sponsor
- Prism Health North Texas
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of lopinavir + ritonavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Prism Health North Texas. Primary endpoint: Tolerability and Acceptance of Kaletra Tablet Formulation. Started Dec 2005; status: completed.
02
Drugs
lopinavir + ritonavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00268827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00268827.